Literature DB >> 9118206

VEGF and bFGF mRNA are expressed in ethylnitrosourea-induced experimental rat gliomas.

T Okimoto1, I Shimokawa, Y Higami, T Ikeda.   

Abstract

1. Which angiogenic growth factors actually mediate tumor growth in ethylnitrosourea (ENU)-induced gliomas in rats was examined. 2. In situ hybridization histochemistry with digoxigenin-labeled oligonucleotide probes was used to investigate the cellular expression and distribution of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) mRNAs in ENU-induced gliomas. 3. Both VEGF and bFGF mRNAs were not detected in normal gial cells but in ENU-induced glioma cells. 4. Our results suggest that the growth of ENU-induced glioma may be regulated by multiple angiogenic growth factors and that these gliomas may proliferate by synthesizing such growth factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118206     DOI: 10.1023/a:1026389306987

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  26 in total

1.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

2.  Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions.

Authors:  M Rentrop; B Knapp; H Winter; J Schweizer
Journal:  Histochem J       Date:  1986-05

3.  Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair.

Authors:  K N Broadley; A M Aquino; S C Woodward; A Buckley-Sturrock; Y Sato; D B Rifkin; J M Davidson
Journal:  Lab Invest       Date:  1989-11       Impact factor: 5.662

4.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.

Authors:  D Zagzag; D C Miller; Y Sato; D B Rifkin; D E Burstein
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

5.  In situ detection of basic fibroblast growth factor by highly specific antibodies.

Authors:  K Schulze-Osthoff; W Risau; E Vollmer; C Sorg
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

6.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Authors:  S Kondo; M Asano; H Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

7.  Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors.

Authors:  S Brem; A M Tsanaclis; S Gately; J L Gross; W F Herblin
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

8.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 9.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989

Review 10.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  1 in total

1.  Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.

Authors:  P E Kish; M Blaivas; M Strawderman; K M Muraszko; D A Ross; B D Ross; G McMahon
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.